Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Patients with Private Insurance Endure Significantly Longer Delays in Time from Intent to CAR-T to Apheresis (Brain-2-Vein) in Multiple Treated Diffuse Large B-Cell Lymphoma: Analysis By Cellular Therapy Intent Quotient (CTIQ)

Matthew Gromowsky, Valerie Shostrom, Kimberly Schmidt-pokorny, James Olen Armitage, Julie M. Vose, Robert Gregory Bociek, Christopher D'Angelo, Matthew A Lunning

Blood (2023) 142 (Supplement 1): 258.

https://doi.org/10.1182/blood-2023-181344

Published: 2023

Journal Articles

Use of Geriatric Assessment and Genetic Profiling to Personalize Selection of Intensive Versus Low Intensity Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML): Final Results of a Phase II Trial

Vijaya Raj Bhatt, Christopher Wichman, Thuy T Koll, Alfred Fisher, Tanya M. Wildes, Michael Haddadin, Ann Berger, James Olen Armitage, Sarah A. Holstein, Lori Maness, Krishna Gundabolu

Blood (2023) 142 (Supplement 1): 4265.

https://doi.org/10.1182/blood-2023-178112

Published: 2023

Journal Articles

Phase I/II Trial of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Avyakta Kallam, MBBS, Jane Meza, PhD, Philip Bierman, MD, Matthew A. Lunning, DO, R. Gregory Bociek, MD, James Olen Armitage, MD, Julie M Vose, MD

Blood (2017) 130 (Supplement 1): 4039.

https://doi.org/10.1182/blood.V130.Suppl_1.4039.4039

Published: 2017

Journal Articles

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Roberto A. Ferro, MD, Valerie Shostrom, MS, Julie M. Vose, MD, Krishna Gundabolu, MD, Smith Giri, MBBS, KM Monirul Islam, MDPhD, Lori J. Maness, MD, James Olen Armitage, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 268.

https://doi.org/10.1182/blood.V126.23.268.268

Published: 2015

Journal Articles

Trend Analysis of Clinical Outcomes in Hodgkin Lymphoma over the Last Three Decades: Report from the Nebraska Lymphoma Study Group

Kailash Mosalpuria, MD MPH, Fausto R Loberiza, MD MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Apar Kishor Ganti, MD, James Olen Armitage, MD, Julie M. Vose, MD, Philip Bierman, MD

Blood (2014) 124 (21): 1284.

https://doi.org/10.1182/blood.V124.21.1284.1284

Published: 2014

Journal Articles

Disparity In Clinical Outcomes Of Elderly Patients With Non-Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation According To Area Of Residence

Andrew C. Cannon, B.S., James Olen Armitage, MD, Philip Bierman, MD, R. Gregory Bociek, MD, Julie M. Vose, MD, Fausto R. Loberiza, Jr., MD, MS

Blood (2013) 122 (21): 1744.

https://doi.org/10.1182/blood.V122.21.1744.1744

Published: 2013

Journal Articles

PET scans: when and how?

James Olen Armitage

Blood (2011) 118 (1): 2–3.

https://doi.org/10.1182/blood-2011-05-352526

Published: 2011

Journal Articles

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

Blood (2010) 115 (5): 1026–1036.

https://doi.org/10.1182/blood-2009-06-227579

Published: 2010

Includes: Supplemental data

Journal Articles

Survival Disparities in Patients with Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study

Fausto R Loberiza, Jr., MD, MS, Anthony J Cannon, Dennis D Weisenburger, MD, Julie M. Vose, MD, Matt J. Moehr, MS, Martin A. Bast, Philip Bierman, MD, R. Gregory Bociek, MD, James Olen Armitage, MD

Blood (2008) 112 (11): 874.

https://doi.org/10.1182/blood.V112.11.874.874

Published: 2008

Journal Articles

Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.

Philip Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Fausto Loberiza, MD, Martin Bast, BS, Dennis D. Weisenburger, MD, James Olen Armitage, MD

Blood (2007) 110 (11): 3451.

https://doi.org/10.1182/blood.V110.11.3451.3451

Published: 2007

Journal Articles

A Prognostic Model of 114 Patients with Castleman’s Disease.

Angela Dispenzieri, MD, Matthew J. Loe, M.D., Susan M. Geyer, Ph.D., Jacob B. Allred, M.S., James Olen Armitage, M.D., John K. Camoriano, M.D., Ahmet Dogan, M.D., David M. Menke, M.D., Thomas M. Habermann, M.D.

Blood (2006) 108 (11): 102.

https://doi.org/10.1182/blood.V108.11.102.102

Published: 2006

Journal Articles

Clinical and Pathological Differences between Nasal and Nasal-Type NK/T Cell Lymphomas: A Summary of 136 Cases from the International T Cell Lymphoma (ITCL) Project.

Wing Au, MD, Tanin Intragumtornchai, MD, Shigeo Nakamura, MD, James Olen Armitage, MD, Raymond Liang, MD

Blood (2006) 108 (11): 292.

https://doi.org/10.1182/blood.V108.11.292.292

Published: 2006

Journal Articles

High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Lymphocyte Predominant Hodgkin’s Disease.

Philip Bierman, MD, Hina Naushad, MD, Fausto Loberiza, MD, R. Gregory Bociek, MD, Julie M. Vose, MD, James Olen Armitage, MD, Patricia Aoun, MD

Blood (2006) 108 (11): 3061.

https://doi.org/10.1182/blood.V108.11.3061.3061

Published: 2006

Journal Articles

Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma.

Philip Bierman, MD, Fausto Loberiza, MD, Bhavana Dave, PhD, Warren Sanger, PhD, R. Gregory Bociek, MD, Martin Bast, BS, Julie M. Vose, MD, James Olen Armitage, MD, Dennis Weisenburger, MD

Blood (2006) 108 (11): 2030.

https://doi.org/10.1182/blood.V108.11.2030.2030

Published: 2006

NARROW

Patients with Private Insurance Endure Significantly Longer Delays in Time from Intent to CAR-T to Apheresis (Brain-2-Vein) in Multiple Treated Diffuse Large B-Cell Lymphoma: Analysis By Cellular Therapy Intent Quotient (CTIQ)

Use of Geriatric Assessment and Genetic Profiling to Personalize Selection of Intensive Versus Low Intensity Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML): Final Results of a Phase II Trial

Phase I/II Trial of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Trend Analysis of Clinical Outcomes in Hodgkin Lymphoma over the Last Three Decades: Report from the Nebraska Lymphoma Study Group

Disparity In Clinical Outcomes Of Elderly Patients With Non-Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation According To Area Of Residence

PET scans: when and how?

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

Survival Disparities in Patients with Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study

Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.

A Prognostic Model of 114 Patients with Castleman’s Disease.

Clinical and Pathological Differences between Nasal and Nasal-Type NK/T Cell Lymphomas: A Summary of 136 Cases from the International T Cell Lymphoma (ITCL) Project.

High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Lymphocyte Predominant Hodgkin’s Disease.

Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only